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ACUTE DYSKERIN DEPLETION TRIGGERS CELLULARSENESCENCE AND
RENDERS OSTEOSARCOMA CELLSRESISTANT TO GENOTOXIC STRESSINDUCED APOPTOSIS
Abstract
Dyskerin is a conserved, nucleolar RNA-binding protein implicated in an increasing array offundamental
cellular processes. Germline mutation in the dyskerin gene (DKC1) is the cause of X-linked dyskeratosis
congenita. Conversely, wild-type dyskerin is overexpressed in sporadiccancers, and high-levels may be
associated with poor prognosis. It was previously reported thatacute loss of dyskerin function via siRNAmediated depletion slowed the proliferation oftransformed cell lines. However, the mechanisms remained
unclear. Using human U2OSosteosarcoma cells, we show that siRNA-mediated dyskerin depletion
induced cellular senescenceas evidenced by proliferative arrest, senescence-associated
heterochromatinization and asenescence-associated molecular profile. Senescence can render cells
resistant to apoptosis.Conversely, chromatin relaxation can reverse the repressive effects of senescenceassociatedheterochromatinization on apoptosis. To this end, genotoxic stress-induced apoptosis
wassuppressed in dyskerin-depleted cells. In contrast, agents that induce chromatin relaxation,including
histone deacetylase inhibitors and the DNA intercalator chloroquine, sensitizeddyskerin-depleted cells to
apoptosis. Dyskerin is a core component of the telomerase complex andplays an important role in
telomere homeostasis. Defective telomere maintenance resulting inpremature senescence is thought to
primarily underlie the pathogenesis of X-linked DC. SinceU2OS cells are telomerase-negative, this leads us
to conclude that loss of dyskerin function canalso induce cellular senescence via mechanisms
independent of telomere shortening.
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Abstract
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Dyskerin is a conserved, nucleolar RNA-binding protein implicated in an increasing array of
fundamental cellular processes. Germline mutation in the dyskerin gene (DKC1) is the cause of Xlinked dyskeratosis congenita. Conversely, wild-type dyskerin is overexpressed in sporadic
cancers, and high-levels may be associated with poor prognosis. It was previously reported that
acute loss of dyskerin function via siRNA-mediated depletion slowed the proliferation of
transformed cell lines. However, the mechanisms remained unclear. Using human U2OS
osteosarcoma cells, we show that siRNA-mediated dyskerin depletion induced cellular senescence
as evidenced by proliferative arrest, senescence-associated heterochromatinization and a
senescence-associated molecular profile. Senescence can render cells resistant to apoptosis.
Conversely, chromatin relaxation can reverse the repressive effects of senescence-associated
heterochromatinization on apoptosis. To this end, genotoxic stress-induced apoptosis was
suppressed in dyskerin-depleted cells. In contrast, agents that induce chromatin relaxation,
including histone deacetylase inhibitors and the DNA intercalator chloroquine, sensitized
dyskerin-depleted cells to apoptosis. Dyskerin is a core component of the telomerase complex and
plays an important role in telomere homeostasis. Defective telomere maintenance resulting in
premature senescence is thought to primarily underlie the pathogenesis of X-linked DC. Since
U2OS cells are telomerase-negative, this leads us to conclude that loss of dyskerin function can
also induce cellular senescence via mechanisms independent of telomere shortening.
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INTRODUCTION
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Dyskerin is a highly conserved nucleolar protein required for the biosynthesis, maturation,
stabilization and function of ribonucleoproteins (RNPs) that incorporate non-coding H/ACA
RNAs [1]. H/ACA RNAs include subsets of small nucleolar RNAs (snoRNAs) and Cajal
body RNAs, respectively, telomerase RNA (TERC) (which harbors an H/ACA domain at its
3′ end) and at least 350 additional RNAs that have yet to be ascribed specific functions [1,
2]. To this end, dyskerin appears to be implicated in an array of fundamental cellular
processes. In addition to well-described roles in telomere maintenance [3] and posttranscriptional processing of nascent rRNA [4], dyskerin has also been implicated in
regulation of spliceosomal RNA maturation [1], internal ribosome entry site (IRES)mediated mRNA translation [5], cell proliferation, morphology and adhesion [6-8], mitotic
progression [9], and processing of a subset of H/ACA snoRNA-derived microRNAs [10,
11]. It is not yet known if dyskerin regulates all of these processes via binding to H/ACA
RNAs. Nonetheless, the biologic importance of dyskerin cannot be understated.
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Complete dyskerin ablation is lethal in mice, Drosophila, and yeast [12]. In humans,
germline mutation in the dyskerin gene (DKC1) is the cause of X-linked dyskeratosis
congenita (DC) [3]. DC is a rare, heritable disorder associated with a wide-ranging and
variably severe phenotype, including aplastic anemia, pulmonary fibrosis, cancer
susceptibility and signs of premature aging. Telomere dysfunction is thought to primarily
underlie the pathogenesis of X-linked DC [4, 13]. Through a direct association with TERC,
dyskerin plays an important role in telomere homeostasis and maintenance of genomic
integrity. Disruption of this interaction impairs telomerase activity, leading to excessive
telomere shortening and premature cellular senescence [4, 13].
Although dyskerin mutation may increase cancer susceptibility, wild-type dyskerin and/or
its mRNA are overexpressed in various sporadic cancer types, and high-levels may be
associated with poor prognosis [14-16]. We and others previously demonstrated that acute
loss of dyskerin function via siRNA-mediated depletion slowed the proliferation of
transformed human cell lines [6, 7]. However, the mechanism remained unclear.
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Described herein, we show that targeted dyskerin depletion induced the senescence of U2OS
osteosarcoma cells as evidenced by proliferative arrest, senescence-associated
heterochromatinization, and a senescence-associated global gene expression profile.
Chromatin compaction can promote cell survival, and this can be reversed through the use of
agents that induce chromatin relaxation [17-19]. To this end, dyskerin-depleted cells were
resistant to apoptosis induced by genotoxic stress, whereas agents that induce chromatin
relaxation sensitized the cells to apoptosis. U2OS cells are telomerase-negative and do not
express either TERC or telomerase reverse transcriptase [6]. This leads us to conclude that
loss of dyskerin can induce cellular senescence via mechanisms independent of telomere
dysfunction.
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MATERIALS AND METHODS
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Cell culture
U2OS cells (American Type Culture Collection, Manassas, VA) were grown in Dulbecco’s
minimal essential medium with GlutaMAX (Invitrogen, Carlsbad, CA) and 10% fetal bovine
serum with 100 IU/mL penicillin and 100 IU/mL streptomycin (Invitrogen). Quality control
was sporadically performed using the Mycoplasma Plus™ PCR Primer Set (Agilent
Technologies, Santa Clara, CA).
siRNA transfections
Custom-designed (#1) and pre-designed (#2) ON-TARGETplus SMARTPool siRNA
duplexes targeting DKC1 and negative control, ON-TARGETplus Non-Targeting siRNA
pools #1 and #2 were obtained from Dharmacon (Lafayette, CO). The siRNA sequences are
listed in Table S1. Transfections were performed using Lipofectamine 2000 (Invitrogen), as
previously described [6].
Chemical reagents and antibodies
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Doxorubicin, neocarzinostatin, trichostatin A, suberoylanilide hydroxamic acid (SAHA),
chloroquine and bafilomycin were obtained from Sigma-Aldrich (St. Louis, MO).
Antibodies recognizing dyskerin and GAPDH were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). All other antibodies, including secondary antibodies, were
obtained from Cell Signaling Technology (Danvers, MA).
Protein extraction and immunoblotting
Protein extractions and Western blots were performed as previously described [6]. In most
cases, the blots were stripped and re-probed with a different antibody.
Cell proliferation and apoptosis analyses
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Proliferation was assessed by incubating the cells with 10 μM 5-ethynyl-2′-deoxyuridine
(EdU) for 16 hours and then analyzed using the Click-iT® EdU Alexa Fluor® 647 Flow
Cytometry Assay Kit (Invitrogen) as per the manufacturer’s protocol. Apoptosis was
measured using the Alexa Fluor® 488 Annexin V/Dead Cell Apoptosis Kit (Invitrogen), as
previously described [9]. Analyses were performed on a BD™ LSR II flow cytometer (BD
Biosciences, Sparks, MD) and tabulated using FlowJo Version 10 (Tree Star, Ashland, OR).
Statistical analyses were performed using Student’s t-test; p < 0.05 was considered
statistically significant.
Indirect immunofluorescence and analysis
Cells were grown and transfected in 4-well Lab Tek chamber slides (Thermo Scientific,
Rochester, NY). At the indicated time points, the cells were fixed, permeabilized,
immunolabeled, and analyzed as previously described [9].
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RNA extraction and analysis

NIH-PA Author Manuscript

Total RNA was isolated using the miRNeasy kit (Qiagen, Valencia, CA) as per the
manufacturer’s protocol. The miScript PCR system (Qiagen) was used for quantitative RTPCR on a 7500 Real Time PCR System (Applied Biosystems, Carlsbad, California). All
Quantitect primers were obtained from Qiagen. Gene expression profiling was performed
using the GeneChip Human Gene 1.0 ST array (Affymetrix, Santa Clara, CA). The
associated technical work and bioinformatics analyses were conducted by the University of
Pennsylvania Molecular Profiling Core.

RESULTS
Almost all of the studies described herein were performed over a 72-144 hour time frame,
depending on the specific experiment. Thus we reasoned that any observed phenotype
associated with dyskerin depletion would not be a result of accelerated telomere shortening.
To further ensure this, we employed telomerase-negative U2OS cells which express
relatively high levels of dyskerin [6, 15]. After 72 hrs, dyskerin expression was reduced
more than 80-90% relative to the controls irrespective of the siRNA used (Fig. S1).
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Loss of dyskerin function arrests cell proliferation
Forty-eight hrs after siRNA transfection there were no appreciable differences in EdU
incorporation between the control (siCTRL) and dyskerin-depleted (siDKC1) cells (Fig.
1A). After 72 hrs siCTRL cells continued to incorporate EdU, whereas siDKC1 cells
showed no additional uptake (p < 0.0001). Cells transfected with two distinct DKC1 siRNAs
(siDKC1 #1 and siDKC1 #2) yielded similar results. This reaffirmed our previous findings
that acute loss of dyskerin function arrested U2OS proliferation [6]. EdU incorporation was
reduced in a relatively equal proportion of siCTRL and siDKC1 cells following 24 hr
treatment with the genotoxic agent doxorubicin (DOXO) (Fig. 1A). In addition to no
appreciable differences in apoptosis between untreated siCTRL and siDKC1 cells (see Fig.
3A), this confirmed that siDKC1 cells were still viable and responsive to genotoxic stress.
Autophagy is not induced by dyskerin depletion
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We and others previously noted that dyskerin-depleted cells exhibited unusual morphology
whereby their cytoplasmic processes were thinned and markedly elongated [6, 7]. As soon
as 72 hrs but more prominently six days after transfection, there was also cytoplasmic
vacuolization with most of the vacuoles arranged in a perinuclear pattern (Fig. 1B). The
vacuoles were qualitatively larger than those seen in siCTRL and GAPDH knockdown cells.
The vacuolization was reminiscent of the autophagosomes that form during the course of
autophagy. Autophagic flux as measured by accumulation of the LC3B cleavage product
(LC3B II) is considered a reliable measure of autophagy; LC3B II is recruited to
autophagosomes [20]. However, whole lysates did not reveal any appreciable increase in
LC3B II or of the autophagy marker Beclin following dyskerin depletion (Fig. 1C). There
was also no increase in autophagic flux following overnight treatment with chemical
autophagy inhibitors chloroquine (CQ) and bafilomycin (Fig. 1D).
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Dyskerin-depleted cells exhibit a senescence-associated gene expression profile
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To identify factors that could help explain the proliferative arrest, we investigated the effects
of dyskerin depletion on global mRNA expression using the GeneChip Human Gene 1.0 ST
array. After 72 hrs of knockdown, loss of dyskerin was associated with a genetic profile in
which only 96 genes were upregulated (p ≤ 0.001) and 142 genes were downregulated at
least 2-fold (p < 0.02) relative to siCTRL cells. As expected, some of the downregulated
genes included DKC1 and H/ACA RNAs (not shown).
No known autophagy regulatory genes were upregulated. Instead, there was an enrichment
(>20%) in genes, including SERPINB5, SPINK1, SPP1, and MMP3, that encode secretory
proteases and other factors that regulate extracellular matrix. Pro-inflammatory genes (IL24,
CFH, DEFB103A, PROS1, CD22), and factors that regulate responses to endogenous stress
(HMOX1, MGST1, TXNIP) were also enriched. A review of the literature revealed that at
least 57/96 (59.4%) of the upregulated genes ( 2-fold), including six of the eight most highly
upregulated genes, show increased levels during senescence and/or organismal aging in
various model systems (Fig. 2A, Supp. Fig S2). Many of these genes are also known to
promote cellular survival and/or confer chemoresistence.
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Downregulated genes included pro-apoptotic genes such as TGFB1, TGFBR1, and notably,
caspase 3 (CASP3); multiple collagens (COL4A1, COL6A3, COL8A1), matrix
metallopeptidases (MMP9, MMP13, MMP14), serine proteases (PRSS1, PRSS2, TRY6),
and chemokines (CCL2, CCL24, CX3CL1). We validated the expression levels of several
factors by qRT-PCR and/or Western blot (Supp. Fig. S3).
Together, this suggested that loss of dyskerin triggered a pro-senescence, anti-apoptotic
molecular signature in U2OS cells that was reminiscent of a senescence-associated secretory
phenotype (SASP). The SASP is characterized by the dysregulated expression of soluble
signaling proteins including growth factors, secretory proteases and other modulators and
components of the extracellular matrix, such as collagens and laminin [21]. We note that
levels of prototypical SASP biomarkers, including IL-6, IL-8, IGFBP5 and VEGF, were
either unaffected or reduced (not shown). However, dyskerin depletion was recently shown
to enhance VEGF protein expression in breast cancer cells [22].
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Loss of dyskerin triggers heterochromatinization in U2OS cells
Senescent cells tend to become flatter and exhibit enlarged nuclei relative to proliferating
cells [17]; this phenotype was not evident in dyskerin-depleted cells. As previously reported
[6, 7], senescence-associated β-galactosidase levels were no different between the siDKC1
and siCTRL cells (not shown). p53 and CDKN1a (p21Cip1/Waf1) are often upregulated
during senescence [17], but their levels were unaffected after dyskerin knockdown (Supp.
Fig. S3 and see Fig. 3). Another senescence marker p16INK4a is inherently silenced in U2OS
cells [23]. This led us and others [6, 7] to previously conclude that acute loss of dyskerin did
not induce senescence. Yet, expression of the SASP prompted us to re-evaluate those
conclusions. In particular, we examined the cells by epifluorescence microscopy for
evidence of senescence-associated heterochromatinization (SAH) as measured by a change
in immuno-localization of lysine 9-trimethylated histone H3 (H3K9Me3) [18, 24]. To this

Biochem Biophys Res Commun. Author manuscript; available in PMC 2015 April 18.

Lin et al.

Page 6

NIH-PA Author Manuscript

end, there was re-distribution of H3K9Me3 from a diffuse nuclear pattern in the control cells
to a more punctate pattern in the siDKC1 cells (Fig. 2B). These changes in chromatin
structure were evident 72 hrs after transfection but most apparent six days after knockdown.
As measured by immunoblot, total H3K9Me3 expression was modestly increased while
native histone H3 levels remained unchanged (Fig. 2C). In contrast, acetylated H3K9
(H3K9Ac) levels were decreased by almost 50% relative to siCTRL cells. Histone
hypoacetylation is also associated with SAH [18, 24]. Together, these findings suggested
that acute loss of dyskerin function induced a senescence-like state.
Loss of dyskerin limits apoptosis induced by genotoxic stress
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SAH can promote cellular survival [17-19]. Previous reports suggest that loss of dyskerin
function renders cells acutely resistant to apoptosis, including that caused by DNA damage
[5, 7, 25]. To assess this in our model system, we knocked down DKC1 for 48 hrs and then
treated the cells with the topoisomerase II inhibitor DOXO, and the radiomimetic
neocarzinostatin, respectively, for 24 hours. As measured by annexin V – propidium iodide
labeling, there was a significant suppression of apoptosis in the siDKC1 cells relative to
siCTRL with all treatments (Fig. 3A; p < 0.001).
Histone deacetylase inhibition sensitizes dyskerin-depleted cells to apoptosis
Histone deacetylase inhibition (HDACi) promotes chromatin relaxation thereby reversing
the repressive effects of SAH on apoptosis [18, 24]. To this end, a 24 hr treatment with the
histone deacetylase inhibitor (HDACi) trichostatin A (TSA) hyper-sensitized siDKC1 cells
to apoptosis. There was increased Annexin V / PI-positive cells (Fig. 3B) and more
complete PARP cleavage (Fig. 3C) relative to siCTRL cells. This was particularly evident
with the 250 nM TSA treatment, but apoptosis of siDKC1 cells was increased with
increasing HDACi concentration (Fig. 3C). Treatment with the HDACi SAHA yielded
similar effects (Fig. 3C).
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We note that like H3K9Ac, acetylated α-tubulin (Ac-tubulin) levels were also decreased in
untreated siDKC1 cells relative to siCTRL cells (Figs. 3B, C). After HDACi treatment,
Actubulin levels were at least equivalent in siCTRL and siDKC1 cells. In contrast, H3K9Ac
levels in HDACi-treated siDKC1 cells typically remained lower than in siCTRL cells after
HDACi treatment. The mechanisms by which loss of dyskerin reduced H3K9 and α-tubulin
acetylation requires further study.
Chloroquine potentiates DOXO-induced apoptosis in dyskerin-depleted cells
CQ intercalates into DNA thereby relaxing chromatin through a mechanism that is distinct
from HDACi [26, 27]. To further test our hypothesis that SAH induced the survival of
dyskerin-depleted cells, transfected cells were treated with DOXO, 100 μM CQ, and CQ +
DOXO, respectively, for 24 hrs. DOXO-induced apoptosis was suppressed in the absence of
dyskerin. Unlike with HDACi, there was no significant increase in apoptosis following
treatment with only CQ. However, the combination of DOXO and CQ significantly
potentiated apoptosis in siDKC1 cells beyond the level seen in siCTRL cells (Fig. 4A, B).
Moreover, total annexin V positivity (live and dead cells) was also increased (Fig. 4C). This
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suggested that co-treatment of CQ with DOXO relieved the suppressive effects of dyskerin
depletion on DOXO-induced apoptosis.

NIH-PA Author Manuscript

CQ is well-regarded as a chemosensitizer and an inhibitor of autophagy [28]. Autophagy has
been shown to limit DOXO-induced apoptosis [20, 29]. Co-treatment with bafilomycin,
another autophagy inhibitor, did not potentiate DOXO-induced apoptosis in siDKC1 cells
(not shown). Moreover, there was no evidence of autophagic flux following DNA damage in
siCTRL and siDKC1 cells (Fig. 4D). Unlike CQ, TSA treatment did not induce autophagic
flux (Fig. 1D). This suggests that the mechanism by which CQ sensitized siDKC1 cells to
DOXO was not through autophagy inhibition. This leads us to conclude that the survival of
siDKC1 cells following DNA damage was attributable to induction of cellular senescence,
and that CQ and HDACi potentiated apoptosis through chromatin modulation, albeit by
different mechanisms. Nonetheless, we cannot exclude the possibility that loss of dyskerin
may have triggered a non-canonical form of autophagy which may have partially
contributed to the survival phenotype. This will require further investigation.

DISCUSSION
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Patient-derived X-linked DC cells exhibit telomere dysfunction and premature senescence
[3, 13]. Our findings suggest that acute loss of dyskerin function can also promote a
senescent state by mechanisms that are independent of telomere shortening. The senescence
phenotypes and the effects of transient and constitutive loss of normal dyskerin function
may be cell-type specific [5, 13, 17, 30]. SAH is also not a universal feature of cellular
senescence; it is preferentially triggered by oncogenic stress [18, 30]. RAS-induced
oncogenic stress has been shown to promote cellular survival in response to genotoxic
stress; HDACi treatment can reverse these effects [18, 31]. Dyskerin has been characterized
as a tumor suppressor [4], and only rarely has loss of tumor suppressor protein function been
linked to SAH [31-33].
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It is possible that the mechanisms by which dyskerin knockdown triggered cellular
senescence may be indirect. Dyskerin depletion is known to increase the turnover of its
binding partners NHP2, NOP10, and NAF1, and reduce functional interactions with SHQ1
[34, 35]. Each of these proteins is implicated in H/ACA RNP biogenesis. Inactivation of
SHQ1 was previously shown to confer resistance to interferon - and retinoic acid-induced
apoptosis [36]. Thus, studies to examine these other H/ACA RNP regulatory proteins in the
context of cellular senescence and apoptosis resistance will be worthwhile.
Loss of dyskerin function also results in decreased levels of H/ACA RNAs [6, 37]. It was
recently reported that Drosophila and human chromatin-associated RNAs are enriched in
snoRNAs [38]. Removal of these snoRNAs resulted in chromatin compaction and
restoration of the RNAs induced chromatin relaxation. Bellodi et al [39] reported that
H/ACA RNP dysfunction resulting from dyskerin mutation may contribute to the diverse
phenotype associated with X-linked DC. Thus, it is conceivable that the effects we observed
in our studies could be mediated by either H/ACA RNAs and/or other proteins that are
dysregulated by dyskerin depletion, rather than directly by dyskerin loss alone. This will be
addressed in future studies.
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Supplementary Material
NIH-PA Author Manuscript

Refer to Web version on PubMed Central for supplementary material.

Acknowledgments
We thank Drs. Monica Bessler, Philip Mason and Sarah Millar for helpful discussions and/or review of the
manuscript, and Dr. John Tobias of the Penn Molecular Profiling Core for the bioinformatics analyses.
This work was supported by funds from National Institutes of Health grant DE021428, the Skin Disease Research
Center of the University of Pennsylvania (NIAMS P30-AR057217) and the Abramson Cancer Center Pilot Projects
Program (P30-CA016520).

Abbreviations

NIH-PA Author Manuscript

DC

dyskeratosis congenita

DOXO

doxorubicin

HDACi

histone deacetylase inhibitor

TSA

trichostatin A

CQ

chloroquine

(SAH)

senescence-associated heterochromatinization
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Dyskerin depletion triggers cellular senescence in U2OS osteosarcoma cells

•

Dyskerin-depleted cells are resistant to apoptosis induced by genotoxic stress

•

Chromatin relaxation sensitizes dyskerin-depleted cells to apoptosis
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Figure 1. Loss of dyskerin triggers a proliferative arrest but not autophagy
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A, Transfected U2OS cells were pulsed for 16 hrs with 10 μM EdU in the presence and
absence of DOXO (0.25 μg/mL) and then analyzed by flow cytometry. VEH = water, which
was the DOXO diluent. B, Six days after transfection, siDKC1 cells exhibited thinned and
elongated cellular processes compared to siCTRL and siGAPDH cells. In addition,
numerous vacuoles could be seen, arranged mostly in a perinuclear pattern (arrows). Two
different DKC1 siRNAs elicited similar morphologic changes as evaluated by phase contrast
microscopy. C, Autophagy markers were not upregulated after dyskerin depletion. D,
Chloroquine (CQ) and bafilomycin (BAF) induced autophagic flux in the presence and
absence of dyskerin. Trichostatin A (TSA) had no effect on LC3B cleavage.
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Figure 2. Dyskerin depletion triggers genetic and epigenetic changes characteristic of cellular
senescence
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A, Genes highlighted in green are either prototypic senescence markers or shown to be
upregulated during senescence / aging in several different studies. Genes highlighted in
yellow have been associated with senescence / aging in at least one published study. B,
Three and six days after transfection, the cells were fixed and labeled with an antibody
recognizing H3K9Me3 and DAPI. The punctate H3K9Me3 staining characteristic of SAH
was evident at the three day time point but more readily apparent six days after transfection.
C, In parallel, whole cell lysates were harvested and assessed by immunoblot 72 hrs after
transfection. Total H3K9Me3 was slightly increased whereas H3K9Ac was reduced by
almost 50% in siDKC1 cells. Using NIH Image J, relative expression was measured as the
densitometric ratios of the marked H3K9 / native H3 in siDKC1 cells normalized to their
respective ratios in siCTRL. Standard deviations were derived from analyses of at least three
independent transfections.
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Figure 3. Apoptosis is suppressed following genotoxic stress but enhanced with histone
deacetylase inhibition in dyskerin-depleted cells
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A, 48 hrs after transfection the cells were treated for 24 hrs with DOXO or neocarzinostatin
(NCS). Floating and adherent cells were collected and apoptosis was assessed. Error bars
denote the standard deviations derived from parallel transfections performed in triplicate
wells. All experiments were performed at least in duplicate; one representative experiment is
shown. B, Cells were treated with either DOXO (0.25 μg/mL) or TSA (250 nM) for 24 hrs.
The cells were sensitized to TSA-induced apoptosis. Left panel, western blot, right panel
flow cytometric analysis. C, Cells were treated for 16 hrs with different concentrations of
TSA or SAHA, respectively. There was increased apoptosis of siDKC1 cells compared to
siCTRL cells as measured by more complete PARP cleavage. As expected, H3K9Ac and
Ac-tubulin levels were increased following HDAC inhibition. **p < 0.001
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Figure 4. Chloroquine sensitizes DOXO-treated siDKC1 cells to apoptosis
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A, Cells were treated with DOXO (0.25 μg/mL), CQ (100 μM), and DOXO+CQ for 24 hrs.
Co-treatment with CQ significantly potentiated DOXO-induced cell death in the absence of
dyskerin. B, Quantification of apoptosis. Error bars denote the standard deviations derived
from parallel transfections performed in triplicate wells. All experiments were performed at
least in duplicate; one representative experiment is shown. C, Total Annexin V positivity
(live and dead cells) was also increased in the co-treated siDKC1 cells. D, CQ but not
DOXO induced autophagic flux in siCTRL and siDKC1 cells. **p < 0.001
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